EVONAP (Nepafenac Ophthalmic Suspension 0.1%) is sterile, topical, ophthalmic, nonsteroidal anti-inflammatory (NSAID) prodrug for ophthalmic use.

EVONAP^® ophthalmic suspension is indicated for the treatment of pain and inflammation associated with cataract surgery.

One drop of EVONAP should be applied to the affected eye (s) three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of postoperative period.

EVONAP (nepafenac ophthalmic suspension) 0.1% is supplied sterile in natural LDPE plastic bottle with dropper with grey high impact polystyrene (HIPS) cap in 5ml pack.

• Shake well before use.
• Use as directed by the physician.
• Keep out of the reach of children.
• Protect from light, heat & moisture.
• Store in cool & dry place at 15°C to 30°C.
• Do not freeze.
• Use Solution within one month after first opening of the bottle.
• Do not touch dropper tip to any surface, as this may contaminate the suspension.
• For Ophthalmic Use only.